Loading clinical trials...
Loading clinical trials...
Purpose: To evaluate the efficiency of Irritable Bowel Syndrome (IBS) patients treatment with the H1-receptor antagonist ebastine. Design: Double blind randomized placebo controlled trial. IBS pati...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
KU Leuven
NCT06681012 · Irritable Bowel Syndrome (IBS), Irritable Bowel Syndrome of Diarrhea Type (IBS-D)
NCT07481422 · Irritable Bowel Syndrome (IBS)
NCT07283341 · Irritable Bowel Syndrome (IBS)
NCT04506593 · Eosinophilic Esophagitis, Gastroesophageal Reflux Disease (GERD), and more
NCT07345377 · Irritable Bowel Syndrome (IBS), Pain, and more
UZ Antwerpen
Edegem, Antwerpen
ZOL (Ziekenhuis Oost-Limburg)
Genk, Limburg
UZ Gent
Ghent, Oost-Vlaanderen
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions